Hypothesis

Chronic intermittent fasting (IF) activates the mitochondrial deacetylase SIRT3 in hematopoietic stem and progenitor cells (HSPCs), which reprograms the metabolism of differentiating myeloid cells. This metabolic shift reduces NLRP3 inflammasome activation, lowers SASP cytokine secretion, and upregulates scavenger receptors that enhance phagocytic clearance of senescent cells. As a result, the immune system transitions from a driver of aging to an active suppressor of tissue senescence.

Mechanistic Rationale

1. SIRT3 links fasting to myeloid metabolism – IF raises NAD⁺ levels, activating SIRT3, which deacetylates and activates superoxide dismutase 2 (SOD2) and reduces mitochondrial ROS in HSPCs (see SIRT3‑dependent ROS control in hematopoiesis)[1]. Lower ROS diminishes NLRP3 inflammasome priming, a key upstream event for IL‑1β and IL‑18 production in senescent macrophages.
2. Inflammasome attenuation curtails SASP – Senescent immune cells secrete IL‑1β, IL‑6, TGF‑β, and other SASP components largely via NLRP3‑caspase‑1 signaling. By suppressing NLRP3, IF‑induced SIRT3 activity should blunt this secretory phenotype, decreasing the paracrine induction of senescence in distant organs.
3. Enhanced senescent‑cell clearance – SIRT3 activation also promotes fatty‑acid oxidation and upregulates expression of scavenger receptors such as SCARA5 and MARCO in monocytes/macrophages. These receptors recognize altered surface ligands on senescent cells (e.g., oxidized phospholipids), increasing phagocytosis. Improved clearance breaks the positive feedback loop where senescent cells impair immune function.
4. Systemic outcome – With fewer SASP‑producing immune cells and more efficient senescent‑cell removal, tissue‑resident senescence markers (p16^INK4a^, SA‑β‑gal) should decline in liver, kidney, and lung, even without direct organ‑targeted interventions.

Testable Predictions

• Prediction 1: In 20‑month‑old mice, a 4‑week IF regimen (alternate‑day 24‑h fast) will increase SIRT3 activity and NAD⁺/NADH ratio in bone‑marrow Lin⁻Sca1⁺cKit⁺ (LSK) cells compared with ad libitum fed controls.
• Prediction 2: IF‑treated mice will show reduced NLRP3 inflammasome activation (lower ASC speck formation, caspase‑1 p20) and decreased SASP cytokines (IL‑1β, IL‑6, TGF‑β) in circulating monocytes and tissue‑resident macrophages.
• Prediction 3: Flow cytometry will reveal elevated SCARA5⁺/MARCO⁺ monocytes/macrophages in IF mice, correlating with increased ex vivo phagocytosis of labeled senescent fibroblasts.
• Prediction 4: Senescent cell burden (p16^INK4a^⁺ cells) in liver, kidney, and lung will be significantly lower in IF mice; this reduction will be abolished by myeloid‑specific SIRT3 knockout (Sirt3^fl/fl LysM‑Cre).
• Prediction 5: Adoptive transfer of IF‑conditioned monocytes into young sedentary recipients will protect against senescence induction caused by sub‑lethal irradiation, whereas transfer of SIRT3‑deficient monocytes will not.

Experimental Approach

1. Animal groups: Young (3 mo) and aged (20 mo) C57BL/6 mice; IF vs. ad libitum; plus myeloid‑specific Sirt3 knockout controls.
2. Interventions: IF protocol (24 h fast every other day) for 4 weeks; monitor body weight, glucose, ketone bodies.
3. Readouts:
   • NAD⁺ metabolites and SIRT3 activity (immunoprecipitation‑deacetylase assay) in LSK cells.
   • NLRP3 inflammasome activation (Western blot for ASC specks, caspase‑1 cleavage).
   • SASP cytokines in plasma and tissue homogenates (ELISA/MSD).
   • Scavenger receptor expression (flow cytometry).
   • Phagocytic assay using pHrodo‑labeled senescent fibroblasts.
   • Tissue senescence (p16^INK4a^ immunostaining, SA‑β‑gal).
4. Statistical analysis: Two‑way ANOVA (age × diet) with post‑hoc Tukey; n≥8 per group for adequate power.

Falsifiability

If IF fails to raise SIRT3 activity in HSPCs, or if SASP reduction and enhanced phagocytosis do not occur despite validated SIRT3 activation, the hypothesis would be refuted. Likewise, if myeloid‑specific SIRT3 deletion does not abolish the IF‑mediated decline in tissue senescence, the proposed mechanism is insufficient.

Broader Impact

Confirming this hypothesis would position metabolic reprogramming of immune progenitors as a leverage point to convert the immune system from an aging accelerator into a regenerative sentinel, offering a translational avenue—intermittent fasting or SIRT3‑activating compounds—to delay multi‑organ degeneration.

References

[1] https://doi.org/10.1038/s41586-021-03547-7 – aged immune system drives senescence and ageing of solid organs [2] https://www.nia.nih.gov/news/senescent-immune-cells-spread-damage-throughout-aging-body – senescent immune cells spread damage [3] https://pmc.ncbi.nlm.nih.gov/articles/PMC12651686/ – From Senescent Cells to Systemic Inflammation [4] https://lifespan.io/news/fighting-inflammation-may-cause-more-senescence/ – Fighting Inflammation May Cause More Senescence [5] https://doi.org/10.1126/science.aax0860 – Immunometabolic T cell failure induces multimorbidity and aging